The 1H21 results reflect solid organic growth, a full six-month contribution from Imaging Queensland, a fourmonth contribution from Ascot Radiology and the net impacts of COVID-19 including the receipt of JobKeeper that enabled the retention and support of our highly skilled workforce.

Group Summary

•  Statutory NPAT of $19.9m after customer contract amortisation, transaction and other costs of $3.3m delivering an Operating NPAT of $23.2m
•  Operating revenue of $170.7m
•  Operating EBITDA $52.0m (30.5% margin)
•  Operating EPS of 11.6 cents on operating NPAT of $23.2m
•  Free cash flow of $42.7m with Net Debt of $137.3m
•  Interim dividend (fully franked) of 5.5 cents per share payable on 6th April 2021

All key financial measures include the application of AASB 161.